Regeneron Pharmaceuticals financials at a glance
| Year | Year | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
$8.31B | $6.56B | $5.15B | $5.87B | $4.86B | $4.10B | $2.82B | $2.10B | $1.38B | $445.82M | $459.07M | $379.27M | $238.46M | $125.02M | $63.45M | $66.19M | $174.02M | $16.07B | $12.17B | $13.12B | $0.00M |
| GM % | Gross Margin % |
|
53.61% | 50.97% | 63.34% | 57.90% | 51.61% | 50.94% | 47.64% | 51.76% | 48.49% | -19.72% | -7.03% | -5.58% | -15.67% | -61.94% | -128.87% | -124.43% | 13.05% | 66.74% | 57.67% | 52.32% | 0.00% |
| OM | Operating Margin |
|
39.65% | 34.24% | 49.25% | 35.41% | 27.38% | 30.51% | 29.22% | 35.30% | 33.20% | -46.02% | -21.23% | -19.54% | -36.17% | -92.28% | -169.68% | -184.62% | 3.24% | 55.67% | 41.03% | 32.27% | 0.00% |
| EPS | Earnings Per Share |
|
$-1.90 | $-1.77 | $-1.59 | $-1.05 | $-0.85 | $-1.26 | $-2.45 | $4.66 | $8.17 | $10.00 | $12.07 | $11.32 | $16.32 | $22.84 | $24.67 | $31.47 | $74.66 | $44.98 | $43.79 | $0.00 | |
| Div. | Dividends |
|
$0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| PR % | Payout Ratio % |
|
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -0.00% | -0.00% | -0.00% | 0 | -0.00% | -0.00% | -0.00% | 0 | 0.00% | 0.00% | 0.00% | 0 |
| Sha. | Shares |
|
105.54m | 109.32m | 108.13m | 106.6m | 107.31m | 105.49m | 101.13m | 98.78m | 95.81m | 91.73m | 88.51m | 80.49m | 79.65m | 66.15m | 57.45m | 56.16m | 55.74m | 104.56m | 106.44m | 106.35m | 107.46m |
| OCF | Operating Cash Flow |
|
$2.62B | $2.43B | $2.20B | $1.31B | $1.49B | $1.33B | $752.44M | $588.60M | $-74.62M | $-141.68M | $99.22M | $-69.94M | $-89.09M | $27.37M | $23.08M | $-30.30M | $-16.91M | $7.08B | $5.01B | $4.59B | $0.00M |
| FCF | Free Cash Flow |
|
$2.00B | $2.00B | $1.81B | $1.03B | $961.46M | $652.85M | $410.15M | $427.33M | $-123.95M | $-198.90M | $-3.35M | $-167.26M | $-123.95M | $8.92M | $20.27M | $-35.26M | $-23.08M | $6.53B | $4.42B | $5.65B | $0.00M |
| FCFS | Free Cash Flow Per Share |
|
$18.62 | $18.32 | $16.79 | $9.73 | $9.30 | $6.33 | $4.17 | $4.41 | $-1.31 | $-2.20 | $-0.01 | $-2.10 | $-1.57 | $0.13 | $0.35 | $-0.63 | $-0.42 | $61.77 | $31.73 | $34.37 | $0.00 |